Patents by Inventor Sandhya PANDE

Sandhya PANDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250313852
    Abstract: The invention provides bidirectional expression vectors comprising Chinese hamster ovary elongation factor 1-? (CHEF1) transcriptional regulatory DNA elements, a gene of interest (GOI), a minimal cytomegalovirus (minCMV) and a selectable marker (SM) and/or a human adenovirus tripartite leader (AdTPL) sequence. The invention also provides method for increasing heterologous protein expression in a host cell comprising culturing the host cell the bidirectional expression vector(s).
    Type: Application
    Filed: June 16, 2025
    Publication date: October 9, 2025
    Inventor: Sandhya Pande
  • Publication number: 20250146020
    Abstract: Described herein are polynucleotide constructs and stable cell lines for inducible production of rAAV virions within which are packaged a payload polynucleotide.
    Type: Application
    Filed: June 21, 2024
    Publication date: May 8, 2025
    Inventors: Kenneth Prentice, Sandhya Pande
  • Publication number: 20250129127
    Abstract: The present disclosure provides polynucleotides, vector systems, cells, and methods for amplifying expression of proteins, such as AAV Rep and Cap proteins or therapeutic proteins (e.g., an antibody). Increased expression of AAV Rep and Cap proteins is useful in increasing production of recombinant AAV virions. Also provided herein are vector systems for inducing amplification of expression of AAV Rep and Cap proteins. Also provided herein are vector systems for inducing amplification of expression of therapeutic proteins. Inducible expression of therapeutic proteins is useful in increasing production of therapeutic proteins.
    Type: Application
    Filed: January 27, 2023
    Publication date: April 24, 2025
    Inventors: Sandhya Pande, Kenneth Prentice, Lindsay Nicole Deis, Adrian Wrangham Briggs
  • Publication number: 20250109410
    Abstract: Described herein are polynucleotide constructs for inducible production of rAAV virions. Also provided are stable cell lines for inducible expression of rAAV virions that include a pay load poly nucleotide.
    Type: Application
    Filed: January 31, 2023
    Publication date: April 3, 2025
    Inventors: Kenneth Prentice, Sandhya Pande, Lauriel Earley, Lindsay Nicole Deis, RIchard Thomas Sullivan
  • Publication number: 20250059538
    Abstract: Provided are compositions and methods for silencing suppressor tRNAs. Further provided are compositions and methods for silencing suppressor tRNAs during AAV production for producing virions comprising sequences coding for suppressor tRNAs.
    Type: Application
    Filed: December 23, 2022
    Publication date: February 20, 2025
    Inventors: Sandhya Pande, Anupama Lakshmanan, Lauriel Earley, Stephen Michael Burleigh, Collin Hauskins, Adrian Wrangham Briggs, Kevin Stein
  • Publication number: 20240360473
    Abstract: Described herein are compositions and methods of using stable cells lines in combination with transient transfection to produce recombinant AAV (rAAV).
    Type: Application
    Filed: March 8, 2024
    Publication date: October 31, 2024
    Inventors: Kenneth Prentice, Sandhya Pande
  • Patent number: 12054738
    Abstract: Described herein are polynucleotide constructs and stable cell lines for inducible production of rAAV virions within which are packaged a payload polynucleotide.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: August 6, 2024
    Assignee: Shape Therapeutics Inc.
    Inventors: Kenneth Prentice, Sandhya Pande
  • Publication number: 20240124850
    Abstract: Disclosed herein are cells and cell lines that are selected for retention of at least two exogenous nucleic acid constructs using a single selective pressure. Also disclosed herein are compositions and methods for generating recombinant cells and cell lines using a single selective pressure.
    Type: Application
    Filed: March 3, 2022
    Publication date: April 18, 2024
    Inventors: Kenneth Prentice, Lindsey Nicole Deis Huffman, Sandhya Pande
  • Publication number: 20220145328
    Abstract: Described herein are polynucleotide constructs and stable cell lines for inducible production of rAAV virions within which are packaged a payload polynucleotide.
    Type: Application
    Filed: July 30, 2021
    Publication date: May 12, 2022
    Inventors: Kenneth Prentice, Sandhya Pande
  • Patent number: 11299760
    Abstract: Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell-cycle inhibitors to growing cell cultures.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: April 12, 2022
    Assignee: Amgen Inc.
    Inventors: Sandhya Pande, Mirna Mujacic
  • Publication number: 20210395793
    Abstract: Methods of modulating the properties of a cell culture expressing a protein of interest are provided. In various embodiments the methods relate to the addition of cell-cycle inhibitors to growing cell cultures.
    Type: Application
    Filed: September 1, 2021
    Publication date: December 23, 2021
    Applicant: Amgen Inc.
    Inventors: Sandhya PANDE, Mirna MUJACIC
  • Patent number: 11130980
    Abstract: Methods of modulating high mannose glycoform content of a protein in a cell culture by contacting the cells expressing the protein of interest with monesin are provided.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: September 28, 2021
    Assignee: Amgen Inc.
    Inventors: Sandhya Pande, Mirna Mujacic
  • Publication number: 20210062217
    Abstract: The invention provides bidirectional expression vectors comprising Chinese hamster ovary elongation factor 1-a (CHEF1) transcriptional regulatory DNA elements, a gene of interest (GO I), a minimal cytomegalovirus (minCMV) and a selectable marker (SM) and/or a human adenovirus tripartite leader (AdTPL) sequence. The invention also provides method for increasing heterologous protein expression in a host cell comprising culturing the host cell the bidirectional expression vector(s).
    Type: Application
    Filed: January 9, 2019
    Publication date: March 4, 2021
    Inventor: Sandhya Pande
  • Publication number: 20160281124
    Abstract: Methods of modulating high mannose glycoform content of a protein in a cell culture by contacting the cells expressing the protein of interest with monesin are provided.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 29, 2016
    Applicant: AMGEN INC.
    Inventors: Sandhya PANDE, Mirna MUJACIC